Novel FRET Immunosensor to Detect Gastric Carcinoma-Causing Bacteria

Rapid detection methods with high sensitivity, selectivity, and specificity in complex environments are essential for detecting bacterial pathogens. In an article published recently in the journal Analytical Biochemistry, the researchers developed a novel fluorescence resonance energy transfer (FRET) immunosensor to detect Helicobacter pylori (H. pylori) bacteria with high sensitivity.

Novel FRET Immunosensor to Detect Gastric Carcinoma-Causing Bacteria​​​​​​​

​​​​​​​Study: Carbon dots and graphene oxide based FRET immunosensor for sensitive detection of Helicobacter pylori. Image Credit: K_E_N/Shutterstock.com

Highly fluorescent and water-dispersible functionalized carbon dots (FCDs) were synthesized from an organic source, followed by the fabrication of a potential fluorescence probe (FCDs-Ab) by conjugating the FCDs with anti-H. pylori antibody. The fluorescence quenching caused due to interactions between FCDs-Ab and graphene oxide (GO) was restored due to the presence of H. pylori.

Characterization of the FRET immunosensor after each step exhibited a linear detection range of 5 x 107 cells per milliliter, and the limit of detection (LOD) was 10 cells per milliliter for H. pylori. The analytical studies on developed FRET immunosensor using spiked food samples revealed decent recovery rates with promising risk assessment capacity in food testing. 

H. pylori and Fluorescent Biosensing Methods

H. pylori is a pathogenic bacterium causing gastrointestinal (GI) tract infections in the human population, sometimes leading to permanent damage to the GI tract. According to World Health Organization (WHO), H. pylori is a class I carcinogen that colonizes the stomach lining and causes liver cancer, gastritis, carcinoma, peptic and duodenal ulcer, and gastric lymphoma. 

Additionally, increasing antibiotic resistance in the human population poses a challenge for optimizing a medical treatment against H. pylori infection. Hence, it is critical to develop an in vitro H. pylori detection method which allows for early infection monitoring caused via contaminated food and water sources. Although techniques like colorimetric or electrochemical sensors, polymerase chain reaction (PCR), enzyme-linked sorbent assays (ELISA), and lateral flow devices are available, these methods are laborious, time-consuming, and require skilled professionals for operation.

To this end, the FRET immunosensor that relies on energy transfer phenomena transfers optical energy from donor to acceptor. Furthermore, carbon nanodots (CDs) or nanocrystal-based biosensors enhance their sensitivity, photostability, water dispersibility, biocompatibility, and reduced toxicity. These nanomaterial-based biosensors can be effectively utilized for drug or gene delivery, metal ion or pathogenic microorganism detection, and in vivo and in vitro bioimaging.

GO is a two-dimensional (2D) carbon material with carboxylic (-COOH), hydroxyl (-OH), and carbonyl (-C=O) surface functionalization. It shows high water dispersion, easy surface modification, biocompatibility, and good physicochemical properties. Additionally, the unique thermal, mechanical, and electronic properties of GOs enable them to serve as energy acceptors in photoluminescent sensors and energy transfer reactions. Moreover, GO surface functionalization with sp2 aromatic rings induces fluorescence quenching via non-radiative dipole-dipole coupling or FRET phenomena.

CDs and GO-based FRET Immunosensor for H. pylori Detection

In the present study, the researchers developed a FRET immunosensor to quantitatively detect H. pylori wherein FCD-Ab served as fluorophore and GO served as a quencher. Characterization of this immunosensor using fluorescence spectroscopy, field emission scanning electron microscope (FESEM), and attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy confirmed the conjugation of Ab with FCD and their subsequent interaction with GO to form FCD-Ab-GO complex.

High-resolution transmission electron microscope (HRTEM) images of FCDs revealed their spherical shape and diameter of approximately 4 nanometers with uniform distribution. Dynamic light scattering (DLS) measurement of FCDs in an aqueous medium confirmed an average particle size of 3.79 nanometers. The ultraviolet-visible (UV-vis) absorption and fluorescence spectroscopy revealed absorption peaks at 332 and 230 nanometers, corroborating n- pie(π)* and π-π* energy transitions of -C=O and alkene (C=C) bonds, responsible for exhibiting fluorescence (FL).​​​​​​​

Various dissimilar pathogens-based assays substantiated the selectivity and specificity of the     FRET immunosensor. Furthermore, its performance comparison with the ELISA assay showed better cell count and lower LOD in the FRET immunosensor. Additionally, the FRET immunosensor's practical applicability was analyzed using spiked food samples, and the results revealed its promising risk assessment capacity in real food.

Conclusion

To summarize, the newly developed FRET-based immunosensor could quantitatively detect the whole cell H. pylori using CDs and GO. The FCDs were synthesized efficiently from an organic source (citric acid) with a high quantum yield. Using a catalytic quantity of Tris during the synthesis of FCD enabled the retention of carboxyl groups on the FCD surface, leveraged for their conjugation with Abs.

The strong fluorescence exhibited by FCD-Ab conjugates helped confirm the successful bioconjugation. FESEM images revealed subsequent FCD-Ab attachment onto GO nanosheet, and fluorescence spectroscopy helped monitor subsequent fluorescence quenching. Furthermore, the fluorescence recovery, due to the presence of the target pathogen, was again monitored using fluorescence spectroscopy. Here, the intensity of peaks in the spectra correlated with the concentration of pathogen in the sample.

Reference

Chattopadhyay, S., Choudhary, M., Singh, H. (2022). Carbon dots and graphene oxide-based FRET immunosensor for sensitive detection of Helicobacter pylori. Analytical Biochemistry https://www.sciencedirect.com/science/article/pii/S0003269722002573?via%3Dihub

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Bhavna Kaveti

Written by

Bhavna Kaveti

Bhavna Kaveti is a science writer based in Hyderabad, India. She has a Masters in Pharmaceutical Chemistry from Vellore Institute of Technology, India, and a Ph.D. in Organic and Medicinal Chemistry from Universidad de Guanajuato, Mexico. Her research work involved designing and synthesizing heterocycle-based bioactive molecules, where she had exposure to both multistep and multicomponent synthesis. During her doctoral studies, she worked on synthesizing various linked and fused heterocycle-based peptidomimetic molecules that are anticipated to have a bioactive potential for further functionalization. While working on her thesis and research papers, she explored her passion for scientific writing and communications.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaveti, Bhavna. (2022, July 07). Novel FRET Immunosensor to Detect Gastric Carcinoma-Causing Bacteria. AZoNano. Retrieved on April 28, 2024 from https://www.azonano.com/news.aspx?newsID=39386.

  • MLA

    Kaveti, Bhavna. "Novel FRET Immunosensor to Detect Gastric Carcinoma-Causing Bacteria". AZoNano. 28 April 2024. <https://www.azonano.com/news.aspx?newsID=39386>.

  • Chicago

    Kaveti, Bhavna. "Novel FRET Immunosensor to Detect Gastric Carcinoma-Causing Bacteria". AZoNano. https://www.azonano.com/news.aspx?newsID=39386. (accessed April 28, 2024).

  • Harvard

    Kaveti, Bhavna. 2022. Novel FRET Immunosensor to Detect Gastric Carcinoma-Causing Bacteria. AZoNano, viewed 28 April 2024, https://www.azonano.com/news.aspx?newsID=39386.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.